Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2025-01-17 00:00:00 ET · period of report 2025-01-16 · accession 0001104659-25-004569 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-01-17 | 2025-01-16 | PTGX | Ali Asif | CFO | S - Sale | $0.00 | -3,918 | 65.4K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-16 | S | D | 2,601 | $0.00 | 62,821 | D | — | — | (F1) Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units. |
| 2 | Common | Common Stock | 2025-01-16 | S | D | 1,317 | $0.00 | 65,422 | D | — | — | (F1) Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units. |